Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (361-370 of 655) with videos related to

Pageof 66
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J B Vermorken, M Clavel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspectiveJ Verweij, A T van Oosterom, R Somers, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials GroupA Sulkes, J Smyth, C Sessa, et al.
Ethiopian Medical Journal|December 24, 2005
Detection of intestinal microsporidiosis in diarrhoeal patients infected with the human immunideficiency virus (HIV-1) using PCR and Uvitex-2B stainTekola Endeshaw, Amha Kebede, Jaco J Verweij, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma GroupV H Bramwell, H T Mouridsen, A Santoro, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 31, 2009
Strongyloidiasis--the most neglected of the neglected tropical diseases?Annette Olsen, Lisette van Lieshout, Hanspeter Marti, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1991
Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinomaV Mattijssen, P H De Mulder, J H Schornagel, et al.
Neurobiology of Disease|January 12, 2026
HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFsDerk Draper, Anna E George, Tineke Veenendaal, et al.
Pageof 66

Showing results (361-370 of 655) with videos related to

Sort By:
Pageof 66
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J B Vermorken, M Clavel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspectiveJ Verweij, A T van Oosterom, R Somers, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials GroupA Sulkes, J Smyth, C Sessa, et al.
Ethiopian Medical Journal|December 24, 2005
Detection of intestinal microsporidiosis in diarrhoeal patients infected with the human immunideficiency virus (HIV-1) using PCR and Uvitex-2B stainTekola Endeshaw, Amha Kebede, Jaco J Verweij, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma GroupV H Bramwell, H T Mouridsen, A Santoro, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 31, 2009
Strongyloidiasis--the most neglected of the neglected tropical diseases?Annette Olsen, Lisette van Lieshout, Hanspeter Marti, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1991
Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinomaV Mattijssen, P H De Mulder, J H Schornagel, et al.
Neurobiology of Disease|January 12, 2026
HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFsDerk Draper, Anna E George, Tineke Veenendaal, et al.
Pageof 66